TOVX

Theriva Biologics, Inc. TOVX

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode TOVX GLMD BIVI NKGN ELAB MLEC ISPC WINT BCTXZ CMMB
6M -55.57 % -52.42 % -88.13 % -79.17 % -79.03 % -96.90 % -57.18 % -90.90 % -70.30 % -60.83 %
YTD -88.21 % -73.48 % -94.17 % -92.76 % -97.37 % -97.26 % -86.01 % -99.79 % -77.10 % -77.93 %
1Y -88.94 % -71.04 % -94.09 % -93.64 % -97.22 % -97.04 % -86.16 % -99.76 % -77.10 % -72.51 %
3Y -98.06 % -99.09 % -99.79 % -99.12 % -99.99 % -98.82 % -98.44 % -100.00 % -77.10 % -79.91 %
5Y -99.79 % -99.86 % -99.92 % -99.12 % -99.99 % -97.71 % -99.73 % -100.00 % -77.10 % -98.67 %
10Y -100.00 % -99.94 % -99.15 % -99.12 % -99.99 % -97.71 % -99.73 % -100.00 % -77.10 % -99.73 %
From the beginning -100.00 % -99.97 % -99.66 % -99.12 % -99.99 % -97.71 % -99.73 % -100.00 % -77.10 % -99.73 %

Dividend